Bank of New York Mellon’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,200
Closed -$9.74K 4476
2023
Q1
$9.74K Hold
1,200
﹤0.01% 4357
2022
Q4
$14.2K Hold
1,200
﹤0.01% 4387
2022
Q3
$17K Hold
1,200
﹤0.01% 4466
2022
Q2
$42K Hold
1,200
﹤0.01% 4382
2022
Q1
$48K Hold
1,200
﹤0.01% 4528
2021
Q4
$51K Hold
1,200
﹤0.01% 4498
2021
Q3
$81K Hold
1,200
﹤0.01% 4364
2021
Q2
$92K Buy
+1,200
New +$92K ﹤0.01% 4231
2019
Q4
Sell
-381
Closed -$19K 4237
2019
Q3
$19K Hold
381
﹤0.01% 4176
2019
Q2
$35K Hold
381
﹤0.01% 4141
2019
Q1
$56K Sell
381
-11
-3% -$1.62K ﹤0.01% 4072
2018
Q4
$62K Hold
392
﹤0.01% 4030
2018
Q3
$96K Hold
392
﹤0.01% 4035
2018
Q2
$88K Sell
392
-71
-15% -$15.9K ﹤0.01% 4010
2018
Q1
$113K Buy
463
+60
+15% +$14.6K ﹤0.01% 4030
2017
Q4
$124K Buy
403
+11
+3% +$3.39K ﹤0.01% 4027
2017
Q3
$143K Buy
392
+222
+131% +$81K ﹤0.01% 3935
2017
Q2
$62K Buy
+170
New +$62K ﹤0.01% 4105
2016
Q4
Sell
-144
Closed -$34K 4317
2016
Q3
$34K Sell
144
-25
-15% -$5.9K ﹤0.01% 4177
2016
Q2
$33K Sell
169
-20
-11% -$3.91K ﹤0.01% 4233
2016
Q1
$81K Hold
189
﹤0.01% 4003
2015
Q4
$72K Hold
189
﹤0.01% 4092
2015
Q3
$51K Hold
189
﹤0.01% 4185
2015
Q2
$56K Buy
189
+19
+11% +$5.63K ﹤0.01% 4143
2015
Q1
$47K Buy
+170
New +$47K ﹤0.01% 4134